Andrea Torchia
Overview
Explore the profile of Andrea Torchia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberto M, Di Civita M, Marinelli D, Torchia A, Cara N, Maltese G, et al.
BJUI Compass
. 2025 Jan;
6(1):e455.
PMID: 39877569
Background: We present a systematic review and meta-analysis of randomized clinical trials (RCTs) with PARPi either as monotherapy or in combination with an androgen receptor-targeted agent (ARTA) in first- and...
2.
Krasniqi E, Filomeno L, Arcuri T, Di Lisa F, Astone A, Cutigni C, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682290
Background/objectives: HER2-positive breast cancer (HER2BC) is an aggressive subtype, with neoadjuvant treatment (NAT) aiming to achieve a pathological complete response (pCR) to improve long-term outcomes. Trastuzumab emtansine (T-DM1) has been...
3.
Di Civita M, Torchia A, Santini D, Marinelli D, Magro V, Cerro M, et al.
Curr Oncol
. 2024 Aug;
31(8):4713-4727.
PMID: 39195335
Introduction: Platinum-based chemotherapy represents the standard of care (SoC) for the first-line treatment of advanced urothelial carcinoma (mUC). The benefit of adding immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy was...
4.
Santamaria F, Roberto M, Buccilli D, Di Civita M, Giancontieri P, Maltese G, et al.
Crit Rev Oncol Hematol
. 2024 Jun;
200:104405.
PMID: 38838928
In the last two-decades, innovative drugs have revolutionized cancer treatments, demonstrating a significant improvement in overall survival. These drugs may present several pharmacokinetics interactions with non-oncological drugs, and vice versa,...
5.
Marinelli D, Gallina F, Pannunzio S, Di Civita M, Torchia A, Giusti R, et al.
Crit Rev Oncol Hematol
. 2023 Oct;
192:104190.
PMID: 37871779
The use of neoadjuvant or perioperative anti-PD(L)1 was recently tested in multiple clinical trials. We performed a systematic review and meta-analysis of randomised trials comparing neoadjuvant or perioperative chemoimmunotherapy to...
6.
Di Noia V, Pimpinelli F, Renna D, Campo F, Cosimati A, Torchia A, et al.
Eur J Cancer
. 2022 Oct;
176:164-167.
PMID: 36223679
No abstract available.
7.
Choi H, Shin D, Yang J, Lee S, Figueiredo C, Sinopoli S, et al.
Nat Commun
. 2022 Feb;
13(1):814.
PMID: 35145096
Smart textiles consist of discrete devices fabricated from-or incorporated onto-fibres. Despite the tremendous progress in smart textiles for lighting/display applications, a large scale approach for a smart display system with...